骨质疏松症患者髂嵴骨活检的形态学分析以及根据ADFR概念采用（1-38）人甲状旁腺激素和二膦酸盐（依替膦酸二钠）进行治疗——汉诺威骨质疏松症研究I - Suppr | 超能文献

Morphological analysis of iliac crest bone biopsies in patients with osteoporosis and treatment according to the ADFR concept with (1-38)hPTH and diphosphonate (EHDP)--Osteoporosis Study I, Hannover.

作者信息

Delling G, Dreyer T, Vogel M, Hahn M, Rittinghaus E F, Hesch R D

机构信息

Abteilung Osteopathologie, Institut für Pathologie der Universität Hamburg.

出版信息

Klin Wochenschr. 1989 May 15;67(10):556. doi: 10.1007/BF01719784.

DOI:10.1007/BF01719784

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Morphological analysis of iliac crest bone biopsies in patients with osteoporosis and treatment according to the ADFR concept with (1-38)hPTH and diphosphonate (EHDP)--Osteoporosis Study I, Hannover.骨质疏松症患者髂嵴骨活检的形态学分析以及根据ADFR概念采用（1-38）人甲状旁腺激素和二膦酸盐（依替膦酸二钠）进行治疗——汉诺威骨质疏松症研究I

Klin Wochenschr. 1989 May 15;67(10):556. doi: 10.1007/BF01719784.

2

[Morphologic study of iliac crest spongiosa in patients with osteoporosis treated according to the ADFR (activation, depression of resorption, formation, repeat the cycle) with parathyroid hormone and diphosphonates (Hannover PTH I study)].[采用甲状旁腺激素和双膦酸盐，根据ADFR（激活、抑制吸收、形成、重复循环）方案治疗骨质疏松症患者的髂嵴松质骨形态学研究（汉诺威甲状旁腺激素I研究）]

Z Orthop Ihre Grenzgeb. 1990 Jan-Feb;128(1):1-5. doi: 10.1055/s-2008-1039852.

3

Results of a stimulatory therapy of low bone metabolism in osteoporosis with (1-38)hPTH and diphosphonate EHDP. Protocol of study I, osteoporosis trial Hannover.使用（1-38）人甲状旁腺激素（hPTH）和双膦酸盐依替膦酸二钠（EHDP）对骨质疏松症低骨代谢进行刺激疗法的结果。研究I方案，汉诺威骨质疏松症试验

Klin Wochenschr. 1988 Oct 3;66(19):976-84. doi: 10.1007/BF01738113.

4

[Morphologic study of iliac crest spongiosa in patients with osteoporosis treated with combination therapy of pulsatile administration of parathyroid hormone (1-38 hPTH) and sequential addition of calcitonin nasal spray].[甲状旁腺激素（1-38 hPTH）脉冲给药联合序贯添加鼻用降钙素治疗骨质疏松症患者髂嵴松质骨的形态学研究]

Med Klin (Munich). 1990 Feb 15;85(2):82-6.

5

Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study.甲状旁腺激素每日治疗对骨质疏松症患者骨微结构和骨转换的影响：一项配对活检研究。

J Bone Miner Res. 2001 Oct;16(10):1846-53. doi: 10.1359/jbmr.2001.16.10.1846.

6

hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses.人甲状旁腺激素1-34联合激素替代疗法治疗骨质疏松症：生化、动力学及组织学反应

Osteoporos Int. 1991 Jun;1(3):162-70. doi: 10.1007/BF01625448.

7

Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH 1-34) therapy.

Metab Bone Dis Relat Res. 1981;3(1):23-30. doi: 10.1016/s0221-8747(81)80019-7.

8

[Therapy of osteoporosis using the ADFR schedule (especially with parathyroid hormone and etidronate)].

Internist (Berl). 1991 Feb;32(2):76-9.

9

Preliminary observations of a form of coherence therapy for osteoporosis.一种治疗骨质疏松症的连贯疗法的初步观察。

Calcif Tissue Int. 1984 May;36(3):341-3. doi: 10.1007/BF02405341.

10

Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1-38) and salmon calcitonin in osteoporotic patients.骨质疏松症患者对序贯给予人甲状旁腺激素（1-38）和鲑鱼降钙素的骨密度和组织形态计量学反应。

Bone Miner. 1991 Jul;14(1):67-83. doi: 10.1016/0169-6009(91)90103-7.

本文引用的文献

1

Preliminary observations of a form of coherence therapy for osteoporosis.一种治疗骨质疏松症的连贯疗法的初步观察。

Calcif Tissue Int. 1984 May;36(3):341-3. doi: 10.1007/BF02405341.